We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Instem Plc | LSE:INS | London | Ordinary Share | GB00B3TQCK30 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 830.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
TIDMINS
Instem plc
09 March 2017
Instem plc
("Instem")
Investor Teach-in
Instem plc (AIM: INS), a leading provider of IT solutions to the global early development healthcare market, announces it will be holding a teach-in for investors and analysts on Tuesday, 28th March 2017.
The event will be held in the Black Bar, upstairs at Rocket Bar, 6 Adams Court, Old Broad Street, London EC2N 1DX from 5pm for a 5.15pm start.
A presentation will be given by the Instem management team, CEO, Phil Reason, and CFO, Nigel Goldsmith, for approximately 45 minutes, at which point there will be an opportunity for questions. The presentation will include an overview of the Company and an outline of their strategy to deliver value for shareholders. No new material financial information will be disclosed. This will be followed by light refreshments and an opportunity to network.
To register for the event, please email instem@walbrookpr.com or call the Walbrook PR team below.
For further information, please contact:
Hot Features
Premium
Instem plc Tel: +44 (0) 1785 825
600
Phil Reason, CEO www.instem.com
Nigel Goldsmith, CFO
N+1 Singer (Nominated Tel: +44 (0) 20 7496 3000
Adviser & Broker)
Richard Lindley
Nick Owen
James White
Walbrook PR Ltd Tel: +44 (0) 20 7933 8780
or
Paul Cornelius instem@walbrookpr.com
Sam Allen
Helen Cresswell
Paul Whittington
About Instem
Instem is a leading supplier of IT applications and services to the early development healthcare market delivering compelling solutions for data collection, analysis and regulatory submissions management. Instem solutions are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organisations for data-driven decision making leading to safer, more effective products.
Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information. Instem supports over 500 clients through offices in the United States, United Kingdom, France, Japan, China and India. To learn more about Instem solutions and its mission, please visit www.instem.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRADMGGFDRLGNZM
(END) Dow Jones Newswires
March 09, 2017 02:01 ET (07:01 GMT)
1 Year Instem Chart |
1 Month Instem Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
